最新ニュース Enfusion (NYSE:ENFN) 株価情報

Enfusion

Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. The products and services that comprise its solution are designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa.

Enfusion Inc

CERo Therapeutics Holdings, Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces it is presenting encouraging preclinical results of lead compound CER-1236 in ovarian cancer during the 2025 SITC Spring Scientific Cellular Therapy for Solid Tumors in San Diego, March 12-14.
In the poster, titled, "TIM-4-L Expression on Ovarian Cancer Samples can be Targeted by Engineered Chimeric Engulfment Receptor T cells without Toxicity," investigators demonstrated that CER-1236&nbsp;treated ovarian cancer cells and did not generate toxicity in animal models (mice).&nbsp; Investigators found that following dosing, assessment of clinical and anatomic pathology after CER-1236 infusion showed T cell engraftment in lymphoid organs, but there were no in-life observations, clinical pathology, nor histopathological evaluations indicating toxicity caused by the compound.&nbsp; The poster is <a href="https://www.globenewswire.com/Tracker?data=91w3j3krpoyqit-09TqATsN4giyeGtvysV83EKgywllgE4KMmvw0SM9FVDVjKmoxQIFX2aAC_xhSYSpND3VZF5oPUPh99RdesVGUd7OAfC4=">available today</a>, March 13, 2025.

Biotech

News

General

CERO

CERo Therapeutics Presents Preclinical Data Demonstrating CER-1236 May Be Targeted To Ovarian Cancer Cells Without Toxicities At 2025 SITC Spring Scientific Cellular Therapy For Solid Tumors Meeting

Foresight and Excava, a leading Indian Tier-One Supplier, intend to establish a locally incorporated partnership or joint venture to invest in manufacturing and sales activities in India. Foresight will be responsible for the technology and know-how transfer while Excava will handle manufacturing and sales activities in the Indian market.&nbsp;
Ness Ziona, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) ("Foresight" or the "Company"), an innovator in 3D perception systems, announced today the signing of a commercial cooperation agreement (the "Agreement") with Excava Attachers Pvt. Ltd. ("Excava"), a leading Indian Tier-One automotive supplier. Under the Agreement, both parties will cooperate to promote Foresight's advanced 3D perception systems across a wide range of sectors, including automotive, off-highway, unmanned aerial vehicles (UAVs), defense, railways and logistics, including autonomous and heavy machinery in India.
Pursuant to the Agreement, the parties will jointly promote Foresight's 3D perception systems in India, which are expected to generate potential revenues of up to $19.5 million from 2025 to 2029. Excava will also introduce Foresight to leading Indian and global automotive original equipment manufacturers (OEMs).

Contracts

FRSX

Foresight Signs Agreement With Excava Attachers Pvt. For Revenue Potential Of Up To $19.5M Between 2025- 2029; Excava Will Also Introduce Foresight To Leading Indian And Global Automotive Original Equipment Manufacturers

Canaccord Genuity analyst Brian McNamara downgrades Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) from Buy to Hold and lowers the price target from $3 to $1.

Downgrades

Price Target

Analyst Ratings

Canaccord Genuity Downgrades Solo Brands to Hold, Lowers Price Target to $1

Baird analyst David Koning maintains Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) with a Outperform and lowers the price target from $40 to $36.

Baird Maintains Outperform on Paymentus Holdings, Lowers Price Target to $36

Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) ("Gorilla" or the "Company") has announced a substantial increase in its full-year 2025 revenue guidance, raising its projection to $100-$110 million, up from the previous estimate of $90-$100 million. This strategic adjustment underscores the growing global demand for AI-driven infrastructure, national cybersecurity solutions and smart city advancements.
In a worldwide exclusive on Schwab Networks, Renato Costa, CEO of Brazil Invest-Abu Dhabi Investment Fund, unveiled the launch of Global Edge Worldwide Fund, a $100 billion infrastructure investment fund dedicated to transforming digital ecosystems across the Americas. Through this vehicle, Renato will deploy $20 billion into United States of America and $80 billion into South America, including Brazil, marking one of the largest investment initiatives of its kind.

Guidance

GRRR

Gorilla Technology Raises 2025 Revenue Guidance From $90M-$100M To $100M-$110M; In A Worldwide Exclusive On Schwab Networks, Renato Costa, CEO Of Brazil Invest-Abu Dhabi Investment Fund, Unveiled The Launch Of Global Edge Worldwide Fund, A $100B Infrastructure Investment Fund Dedicated To Transforming Digital Ecosystems Across The Americas

Baird analyst Rob Oliver maintains Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) with a Neutral and lowers the price target from $500 to $490.

ADBE

Baird Maintains Neutral on Adobe, Lowers Price Target to $490

Baird analyst Wesley Golladay maintains National Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSA#NYSE">NSA</a>) with a Neutral and lowers the price target from $42 to $39.

Baird Maintains Neutral on National Storage, Lowers Price Target to $39

Baird analyst Richard Eastman maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Outperform and lowers the price target from $140 to $110.

Baird Maintains Outperform on Teradyne, Lowers Price Target to $110

<ul>
<li>First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment &nbsp;</li>
<li>ECLIPSE program designed to enable regulatory submissions and support reimbursement and access &nbsp;</li>
<li>Rapid study start indicative of significant unmet need for chronic hepatitis delta treatment</li>
</ul>
Vir Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is designed to evaluate the efficacy and safety of tobevibart in combination with elebsiran in people living with chronic hepatitis delta (CHD). ECLIPSE 1, the first trial of the program to be initiated, and ECLIPSE 2 are Phase 3 trials designed to provide the registrational data needed for submission to multiple regulatory agencies. ECLIPSE 3, a Phase 2b trial, is designed to provide important supportive data to help enable access and reimbursement strategies in key European markets.

Vir Biotechnology Enrolls First Patient In Phase 3 ECLIPSE Registrational Program For Chronic Hepatitis Delta

Baird analyst Andrew Wittmann maintains Bowman Consulting Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWMN#NASDAQ">BWMN</a>) with a Outperform and lowers the price target from $29 to $28.

BWMN

Baird Maintains Outperform on Bowman Consulting Group, Lowers Price Target to $28

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCS#NASDAQ">OCS</a>) with a Buy and maintains $28 price target.

Chardan Capital Maintains Buy on Oculis Holding, Maintains $28 Price Target

Dividends

Annaly Capital Management Increases Dividend From $0.65 To $0.70/Share

<h3>Gainers</h3>
<ul>
<li>Mega Matrix (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MPU#AMEX">MPU</a>) shares rose 9.3% to $0.66 during Thursday's pre-market session. The company's market cap stands at $26.9 million. </li>
<li>iHuman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IH#NYSE">IH</a>) stock rose 8.14% to $2.39. The market value of their outstanding shares is at $124.8 million. </li>
<li>Society Pass (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPA#NASDAQ">SOPA</a>) shares increased by 7.54% to $1.28. The company's market cap stands at $4.6 million. </li>
<li>QMMM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) shares moved upwards by 7.18% to $1.8. The market value of their outstanding shares is at $30.9 million. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock moved upwards by 7.16% to $0.13. The market value of their outstanding shares is at $6.7 million. </li>
<li>Advantage Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADV#NASDAQ">ADV</a>) shares rose 7.1% to $1.81. The company's market cap stands at $581.7 million. As per the press release, Q4 earnings came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lions Gate Enter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGF#NYSE">LGF</a>) shares fell 16.1% to $7.04 during Thursday's pre-market session. The company's market cap stands at $1.6 billion. </li>
<li>HWH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) shares fell 7.7% to $1.56. The market value of their outstanding shares is at $10.1 million. </li>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) stock declined by 7.11% to $0.77. The market value of their outstanding shares is at $13.3 million. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) shares declined by 7.02% to $0.93. The company's market cap stands at $4.2 million. </li>
<li>Cardlytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) shares declined by 6.57% to $1.85. The market value of their outstanding shares is at $94.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>Able View Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABLV#NASDAQ">ABLV</a>) shares declined by 6.31% to $1.04. The company's market cap stands at $51.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ABLV

CDLX

DRCT

QMMM

SOPA

VSME

12 Communication Services Stocks Moving In Thursday's Pre-Market Session

General Motors has joined Pacific Gas &amp; Electric Company's (PG&amp;E) residential Vehicle-to-Everything pilot program, providing eligible customers in Northern and Central California with incentivized pricing for qualifying GM Energy home energy products.
GM Energy is working with utilities like PG&amp;E to leverage GM's bidirectional EV charging technology, which allows compatible GM EVs to supply power back to homes during outages and, in the future, can support the grid by helping balance energy demand, with the goal of ultimately helping improve overall grid resiliency.
Customers enrolled in PG&amp;E's residential Vehicle-to-Everything pilot <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4382342-1&amp;h=2311988317&amp;u=https%3A%2F%2Fwww.pge.com%2Fen%2Fclean-energy%2Felectric-vehicles%2Fgetting-started-with-electric-vehicles%2Fvehicle-to-everything-v2x-pilot-programs.html&amp;a=program">program</a>&nbsp;can receive up to $4,500 in incentives off the price of qualifying GM Energy <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4382342-1&amp;h=1773985455&amp;u=https%3A%2F%2Fgmenergy.gm.com%2Ffor-home%2Fproducts%2Fvehicle-to-home-solutions%3Fppc%3DMICROSOFT_700000002813031_71700000119486907_58700008750829666_p80533906463%26d_src%3D313715%26d_adsrc%3D12403317%26d_campaign%3D71700000119486907%26d_site%3DMICROSOFT%26d_adgroup%3D58700008750829666%26d_keyword%3DGM%2BEnergy%26gclick%3Da4cd4cbd28731a5a0fbc2b08f0599615%26gclid%3Da4cd4cbd28731a5a0fbc2b08f0599615%26gclsrc%3D3p.ds%26msclkid%3Da4cd4cbd28731a5a0fbc2b08f0599615%23unlock&amp;a=home+products">home products</a>&nbsp;that enable bidirectional charging, such as the GM Energy V2H Bundle or Home System. Customers may also be eligible for additional incentives by participating in planned backup power events and by maintaining enrollment through the end of the pilot program.

GM Joins PG&E's Vehicle-To-Everything Pilot, Offers Up To $4.5K In Incentives For GM Energy Home Products With Bidirectional Charging Capability In California; Aims To Improve Grid Resiliency

Earnings

Earnings Beats

LPCN

Lipocine FY24 Sales $11.198M Beat $10.321M Estimate

<h3>Gainers</h3>
<ul>
<li>CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) shares rose 20.9% to $7.46 during Thursday's pre-market session. The company's market cap stands at $61.5 million. </li>
<li>TuHURA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURA#NASDAQ">HURA</a>) stock rose 18.09% to $2.48. The company's market cap stands at $104.8 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares rose 17.69% to $12.44. The market value of their outstanding shares is at $37.8 million. </li>
<li>MeiraGTx Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGTX#NASDAQ">MGTX</a>) shares increased by 14.04% to $7.31. The company's market cap stands at $571.3 million. </li>
<li>Aveanna Healthcare Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAH#NASDAQ">AVAH</a>) stock rose 12.33% to $4.2. The market value of their outstanding shares is at $811.8 million. As per the news, the Q4 earnings report came out today. </li>
<li>Gyre Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GYRE#NASDAQ">GYRE</a>) stock increased by 11.39% to $13.0. The market value of their outstanding shares is at $1.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Y-mAbs Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMAB#NASDAQ">YMAB</a>) stock decreased by 26.5% to $3.61 during Thursday's pre-market session. The company's market cap stands at $161.6 million. </li>
<li>Avenue Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXI#NASDAQ">ATXI</a>) stock decreased by 24.81% to $0.71. The market value of their outstanding shares is at $1.4 million. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares declined by 21.32% to $0.04. </li>
<li>Onconetix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) stock declined by 17.37% to $0.14. The market value of their outstanding shares is at $2.0 million. </li>
<li>electroCore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECOR#NASDAQ">ECOR</a>) stock declined by 15.39% to $11.0. The market value of their outstanding shares is at $73.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares decreased by 12.66% to $8.21. The market value of their outstanding shares is at $332.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANGO

ATXI

AVAH

CRVO

ECOR

GYRE

HEPA

HURA

MGTX

ONCO

XCUR

YMAB

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>FreightCar America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIL#NASDAQ">RAIL</a>) shares increased by 13.4% to $7.07 during Thursday's pre-market session. The company's market cap stands at $133.5 million. The company's, Q4 earnings came out yesterday. </li>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) stock rose 8.82% to $0.74. The company's market cap stands at $36.8 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) stock moved upwards by 8.1% to $0.53. The company's market cap stands at $17.3 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock moved upwards by 8.01% to $3.37. The company's market cap stands at $50.8 million. </li>
<li>Titan Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWI#NYSE">TWI</a>) stock rose 7.57% to $8.8. The market value of their outstanding shares is at $556.1 million. </li>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock increased by 6.29% to $4.56. The company's market cap stands at $9.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) stock declined by 20.6% to $0.26 during Thursday's pre-market session. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) stock decreased by 19.07% to $0.14. The company's market cap stands at $18.2 million. </li>
<li>ConnectM Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) shares fell 16.89% to $0.52. The market value of their outstanding shares is at $15.1 million. </li>
<li>Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) shares decreased by 12.11% to $9.0. The market value of their outstanding shares is at $218.8 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares decreased by 11.02% to $1.05. The company's market cap stands at $18.1 million. </li>
<li>RCM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCMT#NASDAQ">RCMT</a>) stock decreased by 10.04% to $16.05. The market value of their outstanding shares is at $121.9 million. The company's, Q4 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREB

CAPT

CNTM

ELPW

JTAI

RAIL

RCMT

SPIR

WLGS

ZBAI

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) stock moved upwards by 11.2% to $23.0 during Thursday's pre-market session. The market value of their outstanding shares is at $99.5 billion. </li>
<li>SatixFy Communications (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SATX#AMEX">SATX</a>) shares rose 11.11% to $1.5. The company's market cap stands at $125.3 million. </li>
<li>BitFuFu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUFU#NASDAQ">FUFU</a>) shares moved upwards by 9.37% to $4.9. The market value of their outstanding shares is at $798.2 million. </li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) shares rose 8.97% to $220.0. The market value of their outstanding shares is at $7.9 billion. </li>
<li>Boxlight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOXL#NASDAQ">BOXL</a>) stock increased by 8.06% to $1.61. The company's market cap stands at $3.1 million. </li>
<li>Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) stock rose 7.52% to $2.0. The company's market cap stands at $203.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Comtech Telecom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMTL#NASDAQ">CMTL</a>) shares declined by 23.5% to $1.63 during Thursday's pre-market session. The market value of their outstanding shares is at $47.5 million. The company's, Q2 earnings came out yesterday. </li>
<li>UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) stock fell 18.43% to $9.65. The market value of their outstanding shares is at $5.3 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) stock declined by 15.94% to $4.01. The company's market cap stands at $43.7 million. As per the news, the Q4 earnings report came out today. </li>
<li>SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) stock decreased by 13.48% to $16.7. The market value of their outstanding shares is at $5.3 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Greenidge Generation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GREE#NASDAQ">GREE</a>) shares decreased by 11.76% to $0.69. The company's market cap stands at $7.9 million. </li>
<li>AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) stock decreased by 10.78% to $11.34. The company's market cap stands at $138.0 million. As per the press release, Q4 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEYE

AUID

BOXL

CMTL

FUFU

GREE

INTC

PATH

PERF

SatixFy Communications Ltd. Ordinary Share

SATX

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Baird analyst Colleen Kusy maintains Oculis Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCS#NASDAQ">OCS</a>) with a Outperform and raises the price target from $37 to $41.

Baird Maintains Outperform on Oculis Holding, Raises Price Target to $41

Amid recent volatility, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are showing signs of a potential rally, according to insights shared by Jim Cramer.
What Happened: Cramer, the host of CNBC's &#8220;Mad Money,&#8221; analysed Larry Williams&#8216; insights, which suggest that Tesla&#8217;s recent gains could be the start of a significant upward trend. Williams&#8217; proprietary valuation model indicates that Tesla may be undervalued, a condition that historically attracts buyers and leads to stock rebounds.
Cramer noted that Tesla&#8217;s stock has been volatile since the election, initially surging due to Elon Musk&#8217;s proximity to President Donald Trump, but later declining amid Musk&#8217;s controversial role in the administration.
"Right now, it suggests that Tesla should be ready to rally, maybe furiously,&#8221; Cramer said.
See Also:<a href="https://www.benzinga.com/25/03/44296357/spacex-crew-10-astronaut-launch-to-bring-back-stuck-astronauts-delayed-due-to-hydraulics-issue-says-nasa"> SpaceX Delays Mission To Bring Back Astronauts Sunita Williams And Butch Wilmore Due To Hydraulics Issue, Says NASA</a>
Despite recent challenges, Tesla shares began to recover on Tuesday, continuing their ascent on Wednesday with a 7.60% increase.
Cramer highlighted Williams&#8217; charts, which point to a potential bottom for Tesla, suggesting the stock is ready for a rally.
The analysis also identifies seasonal patterns and cycles that historically result in Tesla rallying 80% of the time during this period.
Why It Matters: Tesla has been navigating a turbulent period, marked by a sharp decline in sales and stock value. Earlier this month, Tesla&#8217;s sales in Europe plummeted by 45%, contributing to a significant drop in Elon Musk&#8217;s net worth by $5.2 billion in a week.
This decline has<a href="https://www.benzinga.com/news/25/03/44209579/unprecedented-slide-tesla-sales-plummet-45-in-europe-as-musks-net-worth-dives-5-2b-in-a-week"> pushed</a> Tesla&#8217;s market capitalisation below the $1 trillion mark for the first time since November.
Moreover, JPMorgan analysts have predicted that Tesla will experience its weakest quarter for car deliveries since 2022, with a revised forecast of 355,000 deliveries, down from an earlier estimate of 444,000.
This figure is significantly<a href="https://www.benzinga.com/25/03/44295808/tesla-braces-for-lowest-quarterly-deliveries-since-2022-jpmorgan-predicts-a-brand-has-lost-so-much-value-so-quickly"> below</a> the consensus analyst projection of 430,000. Read more.
Despite these challenges, Elon Musk has<a href="https://www.benzinga.com/markets/equities/25/03/44269513/elon-musk-says-tesla-will-double-us-production-in-2-years-after-trump-backs-ev-giant-amid-stock-slump"> announced</a> plans to double Tesla&#8217;s vehicle production in the U.S. within two years. Musk announced this after Trump hosted an<a href="https://www.benzinga.com/25/03/44266805/trump-turns-white-house-into-tesla-showroom-says-elon-musk-was-treated-very-unfairly-heres-the-car-he-picked-for-himself"> event</a> for Tesla at the White House, followed by Trump's<a href="https://www.benzinga.com/markets/equities/25/03/44268275/trump-buys-tesla-model-s-plaid-gary-black-calls-endorsement-potentially-huge-says-it-could-drive-1-7-million-sales"> purchase</a> of a Tesla Model S Plaid.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="777" height="141" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13074855/TSLA-Edge.jpg" alt="" class="wp-image-822734" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13074855/TSLA-Edge.jpg 777w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13074855/TSLA-Edge-300x54.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13074855/TSLA-Edge-768x139.jpg 768w" sizes="(max-width: 777px) 100vw, 777px" /></figure>
Tesla holds a momentum rating of 83.63% and a growth rating of 55.20%, according to <a href="https://www.benzinga.com/report/tsla">Benzinga&#8217;s Proprietary Edge Rankings</a>. The Benzinga Growth metric evaluates a stock's historical earnings and revenue expansion across multiple timeframes, prioritizing both long-term trends and recent performance. For an in-depth report on more stocks and insights into growth opportunities, <a href="https://www.benzinga.com/screener/top-momentum-stocks">sign</a> <a href="https://www.benzinga.com/screener/top-momentum-stocks">up for Benzinga Edge.</a>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility">following this link.</a>
&nbsp;Read Next:
<a href="https://www.benzinga.com/25/03/44295619/epa-targets-bidens-climate-policies-starts-process-to-reverse-passenger-vehicle-truck-emission-rules">EPA Moves To Overturn Biden-Era Climate Policies, Starts Process To Reverse Passenger Vehicle, Truck Emission Rules</a>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Analyst Color

Equities

Markets

Tech

Media

TSLA

TSLA Stock May See A Significant Upswing, Says Jim Cramer: 'Should Be Ready To Rally, Maybe Furiously'

Press Releases

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ENFN, RDW, NARI, VCSA on Behalf of Shareholders

Legal

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LGTY, AZPN, ENFN on Behalf of Shareholders

Clearwater Analytics Announces Launch of $800 Million Term Loan B

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LGTY, ENFN, ITCI, SSTK on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, AZPN, HEES, NEUE on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, FNA, LGTY, ENFN on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, LGTY, ACCD on Behalf of Shareholders

ENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to Shareholders

Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion

Enfusion Announces Fourth Quarter and Full Year 2024 Results

ACCD

AZPN

CWAN

ENFN

HEES

ITCI

IVAC

LGTY

NARI

NEUE

SSTK

VCSA

Blend Labs

Cipher Mining

Diginex

E2open Parent Holdings, Inc.Class A Common Stock

E2open Parent Holdings

Exodus Movement, Inc. Class A Common Stock

Exodus Movement

BitFuFu

AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A Ordinary Shares)

Comments

Enfusion

ニュース

最新ニュース Enfusion (NYSE:ENFN) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル